Inhibitor Therapeutics, Inc. Interest Expense
Inhibitor Therapeutics, Inc. (INTI) reported Interest Expense of $23.23 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-03-29
- Inhibitor Therapeutics, Inc. interest expense for the quarter ending 2022-12-31 was $3.36K.
- Inhibitor Therapeutics, Inc. interest expense for the quarter ending 2022-09-30 was $7.71K.
- Inhibitor Therapeutics, Inc. interest expense for the quarter ending 2022-06-30 was $6.76K.
- Inhibitor Therapeutics, Inc. interest expense for the quarter ending 2022-03-31 was $5.41K.
- Inhibitor Therapeutics, Inc. interest expense for fiscal 2022 was $23.23K, a 56.59% increase from fiscal 2021.
- Inhibitor Therapeutics, Inc. interest expense for fiscal 2021 was $14.84K.
- Inhibitor Therapeutics, Inc. interest expense for fiscal 2014 was $37.48K, a 1849.09% increase from fiscal 2013.
- Inhibitor Therapeutics, Inc. interest expense for fiscal 2013 was $1.92K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $3.36K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $11.06K derived: sum of 2 quarters · filed 2024-03-29 | $17.82K derived: sum of 3 quarters · filed 2024-03-29 | $23.23K 10-K · filed 2024-03-29 |
| 2022-09-30 | $7.71K 10-Q · filed 2023-11-13 | $14.47K derived: sum of 2 quarters · filed 2023-11-13 | $19.88K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $6.76K 10-Q · filed 2023-08-11 | $12.17K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $5.41K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $14.84K 10-K · filed 2023-03-31 | |||
| 2014-12-31 | $950.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-01 | $2.93K derived: sum of 2 quarters · filed 2016-02-01 | $27.92K derived: sum of 3 quarters · filed 2016-02-01 | $37.48K 10-K · filed 2016-02-01 |
| 2014-09-30 | $1.98K 10-Q · filed 2015-11-04 | $26.97K derived: sum of 2 quarters · filed 2015-08-14 | $36.53K 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $24.99K 10-Q · filed 2015-08-14 | $34.55K 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $9.56K 10-Q · filed 2015-05-13 | |||
| 2013-12-31 | $1.92K 10-K · filed 2015-02-13 | |||
| 2012-09-30 | $20.83K 10-Q · filed 2013-11-14 |